tradingkey.logo

Prophase Labs Inc

PRPH
0.363USD
0.0000.00%
Handelsschluss 02/06, 16:00ETKurse um 15 Minuten verzögert
1.51MMarktkapitalisierung
VerlustKGV TTM

Prophase Labs Inc

0.363
0.0000.00%

mehr Informationen über Prophase Labs Inc Unternehmen

ProPhase Labs, Inc. is a biotech, genomics, and consumer products company. The Company is engaged in providing whole genome sequencing solutions, diagnostic development, such as its potentially life-saving test for the early detection of esophageal cancer and a direct-to-consumer marketing platform for OTC dietary supplements. It develops, manufactures, and commercializes health and wellness solutions. Its Diagnostic services segment provides diagnostic information services to a range of customers in the United States, including health plans, third-party payers and government organizations. Its Consumer products segment is engaged in the research, development, manufacture, distribution, marketing and sale of OTC consumer healthcare products and dietary supplements in the United States and provides personal genomics products and services. The Company also develops and markets dietary supplements under the TK Supplement brand, which includes Legendz XL and Triple Edge XL.

Prophase Labs Inc Informationen

BörsenkürzelPRPH
Name des UnternehmensProphase Labs Inc
IPO-datumJan 16, 1984
CEOKarkus (Ted William)
Anzahl der mitarbeiter96
WertpapierartOrdinary Share
GeschäftsjahresendeJan 16
Addresse711 Stewart Ave, Suite 200
StadtNEW YORK
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl11530
Telefon12153450919
Websitehttps://www.prophaselabs.com/
BörsenkürzelPRPH
IPO-datumJan 16, 1984
CEOKarkus (Ted William)

Führungskräfte von Prophase Labs Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Ted William Karkus
Mr. Ted William Karkus
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
321.53K
--
Dr. Louis Gleckel, M.D.
Dr. Louis Gleckel, M.D.
Independent Director
Independent Director
10.38K
--
Mr. Warren Hirsch, CPA
Mr. Warren Hirsch, CPA
Independent Director
Independent Director
--
--
Ms. Carolina Abenante, Esq.
Ms. Carolina Abenante, Esq.
Independent Director
Independent Director
--
--
Mr. Steven M. Plumb, CPA
Mr. Steven M. Plumb, CPA
Fractional Chief Financial Officer
Fractional Chief Financial Officer
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Ted William Karkus
Mr. Ted William Karkus
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
321.53K
--
Dr. Louis Gleckel, M.D.
Dr. Louis Gleckel, M.D.
Independent Director
Independent Director
10.38K
--
Mr. Warren Hirsch, CPA
Mr. Warren Hirsch, CPA
Independent Director
Independent Director
--
--
Ms. Carolina Abenante, Esq.
Ms. Carolina Abenante, Esq.
Independent Director
Independent Director
--
--
Mr. Steven M. Plumb, CPA
Mr. Steven M. Plumb, CPA
Fractional Chief Financial Officer
Fractional Chief Financial Officer
--
--

Umsatzaufteilung

Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Nach Geschäftsbereich
Nach Region
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.

Aktionärsstatistik

Aktualisiert: Fri, Feb 6
Aktualisiert: Fri, Feb 6
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Karkus (Ted William)
4.89%
Sykon Capital LLC
0.98%
The Vanguard Group, Inc.
0.81%
Susquehanna International Group, LLP
0.61%
Geode Capital Management, L.L.C.
0.46%
Andere
92.25%
Aktionäre
Aktionäre
Anteil
Karkus (Ted William)
4.89%
Sykon Capital LLC
0.98%
The Vanguard Group, Inc.
0.81%
Susquehanna International Group, LLP
0.61%
Geode Capital Management, L.L.C.
0.46%
Andere
92.25%
Aktionärstypen
Aktionäre
Anteil
Individual Investor
5.05%
Investment Advisor
2.97%
Investment Advisor/Hedge Fund
0.63%
Hedge Fund
0.09%
Research Firm
0.07%
Venture Capital
0.04%
Andere
91.15%

Institutionelle Beteiligung

Aktualisiert: Thu, Jan 1
Aktualisiert: Thu, Jan 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q4
80
256.11K
3.90%
-408.05K
2025Q3
86
3.04M
7.33%
-2.51M
2025Q2
91
7.80M
18.77%
+525.30K
2025Q1
95
8.38M
29.57%
+1.62M
2024Q4
97
6.02M
20.15%
-197.61K
2024Q3
101
5.16M
20.53%
-1.27M
2024Q2
102
5.11M
20.47%
-1.25M
2024Q1
100
5.62M
31.27%
-1.27M
2023Q4
102
5.60M
32.69%
-985.39K
2023Q3
105
5.94M
34.65%
-718.97K
Mehr Anzeigen

Aktionärsaktivitäten

Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Karkus (Ted William)
321.53K
5.34%
--
--
Apr 29, 2025
Sykon Capital LLC
64.48K
1.07%
--
--
Sep 30, 2025
The Vanguard Group, Inc.
53.19K
0.88%
+12.37K
+30.29%
Sep 30, 2025
Susquehanna International Group, LLP
39.79K
0.66%
+29.59K
+290.03%
Sep 30, 2025
Geode Capital Management, L.L.C.
30.29K
0.5%
+4.39K
+16.93%
Sep 30, 2025
Hightower Advisors, LLC
23.73K
0.39%
+789.00
+3.44%
Sep 30, 2025
Gleckel (Louis)
10.38K
0.17%
--
--
Apr 29, 2025
Swisspartners Investment Network AG
5.00K
0.08%
--
--
Dec 31, 2024
Two Sigma Investments, LP
4.75K
0.08%
+964.00
+25.48%
Sep 30, 2025
Mehr Anzeigen

Verbundene ETFs

Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
Dimensional US Core Equity 1 ETF
0%
Avantis US Equity ETF
0%
Avantis US Small Cap Equity ETF
0%
iShares Micro-Cap ETF
0%
Dimensional US Core Equity 1 ETF
Anteil0%
Avantis US Equity ETF
Anteil0%
Avantis US Small Cap Equity ETF
Anteil0%
iShares Micro-Cap ETF
Anteil0%

Dividende

In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten

Aktien-Split

Datum
Ex-Dividendentag
Art
Verhältnis
Dec 12, 2025
Merger
10→1
Datum
Ex-Dividendentag
Art
Verhältnis
Dec 12, 2025
Merger
10→1
KeyAI